Breast cancer is categorized into four subtypes based on the presence or absence of hormone receptors—estrogen receptor (ER) and progesterone receptor (PgR)—which serve as therapeutic targets, as well as the expression of HER2. This evidence concerns the gene PGR and breast carcinoma.